The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comparison of the clinical treatment score with the adjuvant online score and the risk for recurrence score for estimating prognosis in early-stage high-risk breast cancer patients: A Hellenic Cooperative Oncology Group study.
Kyriaki Pliarchopoulou
No relevant relationships to disclose
Eleni P. Galani
No relevant relationships to disclose
Ralph M Wirtz
Employment or Leadership Position - STRATIFYER Molecular Pathology
Consultant or Advisory Role - STRATIFYER Molecular Pathology
Stock Ownership - STRATIFYER Molecular Pathology
George Kouvatseas
No relevant relationships to disclose
Flora Zagouri
No relevant relationships to disclose
Helen Gogas
No relevant relationships to disclose
Angelos Koutras
No relevant relationships to disclose
George E. Pentheroudakis
No relevant relationships to disclose
Georgios Lazaridis
No relevant relationships to disclose
Nikolaos Pisanidis
No relevant relationships to disclose
Gerasimos Aravantinos
No relevant relationships to disclose
Pavlos Papakostas
No relevant relationships to disclose
Paris Makrantonakis
No relevant relationships to disclose
Konstantine T. Kalogeras
No relevant relationships to disclose
George Fountzilas
Research Funding - Stratifyer Molecular Pathology GmbH
Flora Stavridi
No relevant relationships to disclose